Moderna Slides Up to 25% as Cancer Vaccine Meets Sky-High Expectations
Photo: BeInCrypto
Moderna fell up to 25% despite a cancer vaccine that cut melanoma recurrence or death risk 42%, as expectations ran high.
Source: BeInCrypto
An independent desk covering Stake, the US casino market and crypto.
Photo: BeInCrypto
Moderna fell up to 25% despite a cancer vaccine that cut melanoma recurrence or death risk 42%, as expectations ran high.
Source: BeInCrypto
